日本COVID-19患者的补充激活和肺损伤:一个前性观察性研究
Kentaro Seki1, Koichiro Sueyoshi2, Yukari Miyoshi1
1Department of Emergency and Critical Care Medicine, Juntendo University Urayasu Hospital, Urayasu, Chiba, Japan.
Scientific reports
|October 22, 2024
概括
补充激活会加剧COVID-19患者的肺损伤. 虽然补充因子不能预测机械通风需求,但高的syndecan-1可能表明疾病的严重程度.
科学领域:
- 免疫学 免疫学 免疫学
- 病理生理学 病理生理学
- 关键护理医学 关键护理医学
背景情况:
- 在COVID-19患者中,炎症性细胞因子的增加会导致中性粒细胞和单细胞向肺部迁移.
- 这种迁移会损害空气-血液屏障,影响支气管上皮和血管内皮细胞.
- 补充激活,涉及到败血症引起的器官功能障碍,可能会导致COVID-19肺部损伤.
研究的目的:
- 调查补充激活与COVID-19的病理生理学之间的关联.
- 探索补充因素和监管机构在COVID-19进展中的作用.
主要方法:
- 招募了27名COVID-19患者,分为侵入性机械通风 (IMV) 和非IMV组.
- 使用ELISA测量了补充因子 (C3a,C5a,Ba,sC5b-9),补充调节剂 (sCD59,H因子),互白素-6 (IL-6) 和合成素-1的血水平.
主要成果:
- 在COVID-19患者和健康对照人群中,补充因子,调节剂,IL-6和syndecan-1的水平显著升高.
- 与非IMV组相比,IMV组的C5a和sC5b-9水平下降.
- 与非IMV组相比,IMV组的syndecan-1水平显著增加.
结论:
- 补充激活是COVID-19相关的肺损伤的一个加剧因素.
- 补充因素不是COVID-19患者机械通风的基本预测因素.
- Syndecan-1显示出作为COVID-19严重程度的生物标志物的潜力.
相关概念视频
COPD: Pathogenesis and Clinical Features
238
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
238
Pneumonia II: Pathophysiology
225
The pathophysiology of pneumonia involves the following steps:
225
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Acute Respiratory Failure-II
174
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
174
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
1
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
1
Acute Respiratory Failure-I
176
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
176


